A new meta-analysis reveals cancer patients who have an incidental pulmonary embolism should receive long-term anticoagulation.

“Our study confirms the high risk of recurrent VTE in patients with cancer-associated incidental pulmonary embolism, but it also provides outcomes if patients are left untreated,” said lead author Tom van der Hulle, MD, of Leiden University Medical Center in the Netherlands, at a press briefing held during the American Society of Hematology (ASH) 56th Annual Meeting.